期刊文献+

重组溶葡萄球菌酶对金黄色葡萄球菌生物被膜的体外清除作用 被引量:5

In vitro eradication of S.aureus biofilms by recombinant lysostaphin
下载PDF
导出
摘要 目的研究重组溶葡萄球菌酶对金黄色葡萄球菌生物被膜的体外清除作用。方法使用硅橡胶膜片建立金黄色葡萄球菌生物被膜的体外模型;使用超声震荡—活菌计数法作为金黄色葡萄球菌生物被膜的定量检测方法,分别测定在给予重组溶葡球菌酶及其对照药作用前后金黄色葡萄球菌生物被膜中的活菌数;使用扫描电镜作为金黄色葡萄球菌生物被膜的直观定性检测方法,分别观察在给予重组溶葡球菌酶及其对照药作用前后金黄色葡萄球菌生物被膜的镜下形态。结果经72 h连续培养,金黄色葡萄球菌在硅橡胶片上形成较为成熟的生物被膜,不同浓度重组溶葡球菌酶作用24 h后被膜中的活菌计数明显低于对照药去甲万古霉素,电镜结果进一步支持此结果。结论重组溶葡萄球菌酶能够有效地清除金黄色葡萄球菌生物被膜。 Objective To investigate the in-vitro eradication of S. aureus biofilm by recombinant lysostaphin. Methods The in-vitro biofilms of S. aureus were established on silica gel plates. The biofilms were then treated with recombinant lysostaphin or norvancomycin, compared with those untreated as controls. Before and after treatment, ultrasonic viable bacterial count as a measure of quantitative assessment was evaluated in these biofilms. Scanning elec- tron microscopy (SEM) was employed to study the morphology of bacterial biofilms with or without treatment. Results After continuous cultivation for 72 hours, mature biofilms of S. aureus were found to form on silica gel plates. The viable bacterial counts of biofilm after 24h incubation with recombinant lysostaphin were obviously lower than those with norvancomycin. This finding was further supported by subsequent SEM. Conclusion Recombinant lysostaphin appeared useful for effective eradication of S. aureus biofilm.
出处 《中国药物与临床》 CAS 2008年第7期515-518,共4页 Chinese Remedies & Clinics
基金 国家自然科学基金资助项目(30472058 30672502) 国家高技术研究发展计划(863计划)基金资助项目(2003AA2Z347D) 北京市自然科学基金资助项目(7062044)
关键词 葡萄球菌 金黄色 溶葡萄球菌酶 体外研究 Staphylococcus aureus Lysostaphin In vitro
  • 相关文献

参考文献14

  • 1O'Grady N, Alexander M, Dellinger E, et al. Guidelines for the prevention of intravascular catheter related infections. Pediatrics, 2002,110(5):51. 被引量:1
  • 2Climo MW, Ehlert K, Archer GL. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother,2001 45(5) : 1431-1437. 被引量:1
  • 3Oluola O, Kong L, Fein M, et al. Lysostaphin in treatment of neonatal staphylococcus aureus infection. Antimicrob Agents Chemother, 2007, 51(6):2198-2200. 被引量:1
  • 4Shah A, Mond J, Walsh S. Lysostaphin-coated catheters eradicate staphylococccus aureus challenge and block surface colonization. Antimicrob Agents Chemother,2004,48(7): 2704-2707. 被引量:1
  • 5Yang XY, Li CR, Lou RH, et al. In vitro activity of recombinant lysostaphin against staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol, 2007,56(Pt 1 ) : 71-76. 被引量:1
  • 6杨信怡,张伟新,李聪然,娄人慧,刘京芳,陈慧贞,母立新,黄青山,蒋建东,游雪甫.重组溶葡球菌酶治疗小型猪皮肤烫伤MRSA感染[J].中国新药杂志,2007,16(18):1477-1481. 被引量:3
  • 7CLSI. Performance standards for antimicrobial susceptibility testing. Seventeenth Informational Supplement, 2007,27 (1) : M 100- S17. 被引量:1
  • 8Prosser B La T, Taylor D, Dix BA, et al. Method of evaluating effects of antibiotics on bacterial biofilm.Antimicrob Agents Chemother, 1987,31 (10) : 1502-1506. 被引量:1
  • 9Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated Infections. J Clin Microbiol, 2001,39(6) :2151-2156. 被引量:1
  • 10Esilva GDI, Kantzanou M, Justice A,et al. The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol,2002,40(2):382-388. 被引量:1

二级参考文献9

共引文献2

同被引文献140

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部